Nexplanon and Idiopathic guttate hypomelanosis - a phase IV clinical study of FDA data

Summary:

We study 46,445 people who take Nexplanon (etonogestrel) or have Idiopathic guttate hypomelanosis. No report of Idiopathic guttate hypomelanosis is found in people who take Nexplanon.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Nexplanon?

Nexplanon has active ingredients of etonogestrel. It is often used in birth control. eHealthMe is studying from 46,431 Nexplanon users. Check the latest studies of Nexplanon.

What is Idiopathic Guttate Hypomelanosis?

Idiopathic guttate hypomelanosis (skin disorder that causes small lesions on exposed areas of the skin, such as the face and neck) is found to be associated with 17 conditions by eHealthMe. Check the latest studies of Idiopathic guttate hypomelanosis.

On Feb, 02, 2026

No report is found.

Do you take Nexplanon and have Idiopathic guttate hypomelanosis?

- Check whether Idiopathic guttate hypomelanosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nexplanon:

Nexplanon (46,431 reports)

Browse all side effects of Nexplanon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Idiopathic guttate hypomelanosis:

Idiopathic guttate hypomelanosis

Browse all the conditions that are associated with Idiopathic guttate hypomelanosis:

Idiopathic guttate hypomelanosis

Drugs similar to Nexplanon and Idiopathic guttate hypomelanosis :

How the study uses the data?

The study uses data from the FDA. It is based on etonogestrel (the active ingredients of Nexplanon) and Nexplanon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.